
NBE-Therapeutics is a privately owned Swiss, Basel-based Biotech company that was founded in 2012 with the vision to develop next-generation ADCs improving treatment options for cancer patients. The company is financially backed by the Boehringer Ingelheim Venture Fund and additional private investors.
It is NBE Therapeutics vision to become a leader in antibody-based drug development by developing its own portfolio of drugs until demonstration of a clinical proof-of-concept in man.
Developer of antibody based drugs. The company engages in providing antibody drug conjugates for the treatment of cancer.

Рассказать NBE Therapeutics о своем интересе к работе в компании, сохраняя анонимность. Comparably предоставит NBE Therapeutics возможность нанять вас. Как только появится подходящая вакансия -- мы сделаем так, чтобы вы нашли друг друга.
Отправьте им приглашение, чтобы оценить культуру внутри компании.